For­mer In­di­v­ior med­ical lead who pled guilty to false opi­oid mar­ket­ing now seeks FDA hear­ing to es­cape de­bar­ment

Tim­o­thy Bax­ter, who was sen­tenced last De­cem­ber to six months home de­ten­tion and fined $100,000 for send­ing false and mis­lead­ing in­for­ma­tion on the opi­oid ad­dic­tion drug Sub­ox­one, is now seek­ing to de­bate the FDA’s pro­pos­al to de­bar him.

Bax­ter, the for­mer med­ical di­rec­tor of In­di­v­ior, pre­vi­ous­ly ad­mit­ted that he failed to pre­vent In­di­v­ior from send­ing false and mis­lead­ing in­for­ma­tion to the Mass­a­chu­setts Med­ic­aid pro­gram on the rel­a­tive safe­ty of a film ver­sion of Sub­ox­one for chil­dren.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER